Jane Street’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$247K Sell
36,531
-17,964
-33% -$173K ﹤0.01% 9615
2026
Q2
$589K Buy
+54,495
New +$405K ﹤0.01% 7651
2025
Q1
– Sell
-648
Closed -$7.29K – 10340
2024
Q4
$7.29K Buy
648
+140
+28% +$2.08K ﹤0.01% 9202
2024
Q3
$9.8K Sell
508
-5,662
-92% -$148K ﹤0.01% 9355
2024
Q2
$139K Buy
6,170
+5,872
+1,970% +$175K ﹤0.01% 8615
2024
Q1
$15.3K Sell
298
-1,628
-85% -$90.4K ﹤0.01% 8926
2023
Q4
$136K Sell
1,926
-459
-19% -$31.7K ﹤0.01% 8442
2023
Q3
$175K Buy
2,385
+1,954
+453% +$203K ﹤0.01% 7710
2023
Q2
$64.4K Buy
+431
New +$59.6K ﹤0.01% 8149
2023
Q1
– Sell
-234
Closed -$21.5K – 9713
2022
Q4
$21.5K Buy
+234
New +$50.7K ﹤0.01% 8592
2022
Q2
– Sell
-348
Closed -$136K – 10572
2022
Q1
$136K Buy
+348
New +$104K ﹤0.01% 9293

Other funds holding PIII

Jane Street's PIII Position: Q3 2026 in Review

Jane Street reduced its P3 Health Partners (PIII) stake by 33% in Q3 2026, selling an estimated $173K and leaving 36,531 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #9615.

Jane Street first reported a position in PIII in Q1 2022 and has held it in 11 quarters since. The position peaked at $589K in Q2 2026. 17 funds tracked by Wall St. Rank hold PIII as of Q3 2026.

  • Jane Street held 36,531 shares of P3 Health Partners worth $247K as of Q3 2026.
  • Jane Street sold 17,964 P3 Health Partners shares in Q3 2026, an estimated $173K.
  • P3 Health Partners made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9615 holding.
  • Jane Street first reported a position in P3 Health Partners in Q1 2022 and has held it in 11 quarters since.
  • Jane Street's P3 Health Partners position peaked at $589K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.